Alucent Biomedical Revenue, Growth & Competitor Profile

DBA ALUCENT MEDICAL INC

Company Profile & Annual Report for Alucent Biomedical

Access the complete profile.

Alucent Biomedical Fast Facts

Revenue	$1 - $10 million    See Exact Annual Revenue
Employees	10 - 100Exact Company Size
Primary Industry	621511 Medical Laboratories
Address	675 S. Arapeen Dr Suite 102 Salt Lake City, UT 84108

Note: Revenues for privately held companies are statistical evaluations.


Alucent Biomedical's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Alucent Biomedical's annual revenues are $1 - $10 million (see exact revenue data)
• What industry is the company in?
  • Alucent Biomedical is classified as operating in the Medical Laboratories industry, NAICS Code 621511.

Alucent Biomedical Annual Revenue and Growth Rate

Alucent Biomedical	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2025	$1 - $10 million Details in Premium Report
2024
2023
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Alucent Biomedical's revenues are gauged from an analysis of company filings.

Alucent Biomedical's Income Statement (based on Industry Averages)

Alucent Biomedical P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Alucent Biomedical is developing and marketing. Alucent Biomedical doesn't have any recent trademark applications, indicating Alucent Biomedical is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
ALUCENT NVS Medical devices, namely, catheters, light fibers, and light sources for treatment of vascular diseases	12/08/2019
ALUCENT NVS VESSEL RESTORATION SYSTEM Medical devices, namely, catheters, light fibers, and light sources for treatment of vascular diseases	12/08/2019
ALUCENT NVS VESSEL RESTORATION SYSTEM WITH PHOTOACTIVATED LINKING Medical devices, namely, catheters, light fibers, and light sources for treatment of vascular diseases	12/08/2019

See all trademarks and details in the Full Report.

Market Share of Alucent Biomedical's Largest Competitors

A competitive analysis shows these companies are in the same general field as Alucent Biomedical, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
PHYSICIANS IMMUNODIAGNOSTIC LABORATORY	Burbank, CA	100
ACCU REFERENCE MEDICAL LAB LIMITED LIABILITY	Linden, NJ	100
CENTOGENE US	Cambridge, MA	88
LATARA ENTERPRISE	Pomona, CA	61
TELIGENT PHARMA	Vineland, NJ	46
COVID CLINIC	Huntington Beach, CA	37
VIKOR SCIENTIFIC	Charleston, SC	33
BIOTHERANOSTICS	San Diego, CA	31
SHERMAN-ABRAMS LABORATORY	Brooklyn, NY	31

Nearby Competitors

These companies are similar in business line and location to Alucent Biomedical. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
MYRIAD GENETIC LABORATORIES	Slc, UT	100
LINEAGEN	Salt Lake City, UT	1
CIBUS BIOTECHNOLOGIES	Salt Lake City, UT	1
PYREXAR MEDICAL	West Valley City, UT	1
ALUCENT BIOMEDICAL	Salt Lake City, UT	1
XCR DIAGNOSTICS	Salt Lake City, UT	1

Future Competition: Alucent Biomedical's Fastest Growing Competitors

These companies are in the same general field as Alucent Biomedical and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)